Botulinum toxin-A (Botox®) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: A systematic literature review

Journal of Pediatric Urology

Volumn 5, Issue 3, 2009, Pages 156-164

  Gamé, Xavier ^a   Mouracade, Pascal ^b   Chartier Kastler, Emmanuel ^c   Viehweger, Elke ^d   Moog, Raphael ^b   Amarenco, Gérard ^e   Denys, Pierre ^f   De Seze, Marianne ^g   Haab, François ^h   Karsenty, Gilles ⁱ   Kerdraon, Jacques ^j   Perrouin Verbe, Brigitte ^k   Ruffion, Alain ^l   Soler, Jean Marc ^m   Saussine, Christian ^b  

^a CHU RANGUEIL   (France)

^b HÔPITAL CIVIL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d TIMONE HOSPITAL   (France)

^e HÔPITAL ROTHSCHILD   (France)

^f RAYMOND POINCARÉ HOSPITAL   (France)

^g HÔPITAL PELLEGRIN   (France)

^h HÔPITAL TENON   (France)

ⁱ HÔPITAL SAINTE MARGUERITE   (France)

^j Centre Mutualiste de Kerpape   (France)

^k CHU DE NANTES   (France)

^l Hopital Henry Gabrielle   (France)

^m Centre Bouffard Vercelli   (France)

more..

Author keywords

Botulinum toxin A; Children; Neurogenic; Overactive bladder; Urinary incontinence; Urodynamics

Indexed keywords

BOTULINUM TOXIN A; MUSCARINIC RECEPTOR BLOCKING AGENT;

CHILD; CLINICAL STUDY; CYSTOSCOPY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBASE; GENERAL ANESTHESIA; HUMAN; INJECTION SITE PAIN; INTRADETRUSOR INJECTION; MEDLINE; MENINGOMYELOCELE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; OVERACTIVE BLADDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS;

BOTULINUM TOXIN TYPE A; CHILD; HUMANS; NEUROMUSCULAR AGENTS; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE;

EID: 67349224627     PISSN: 14775131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpurol.2009.01.005     Document Type: Review

References (25)

1. Gamé X., Grima F., Chartier-Kastler E., and Ruffion A. Troubles vésico-sphinctériens et sexuels des spina bidida et myélomeningocèles. Prog Urol 17 (2007) 352-357
2. Hernandez R.D., Hurwitz R.S., Foote J.E., Zimmern P.E., and Leach G.E. Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol 152 (1994) 1582-1585
3. Van Ermengem E. Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Zeitsch Hyg Infekt 26 (1897) 1-56
4. Montecucco C., and Schiavo G. Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 28 (1995) 423-472
5. Chapple C., and Patel A. Botulinum toxin - new mechanisms, new therapeutic directions?. Eur Urol 49 (2006) 606-608
6. Apostolidis A., Dasgupta P., and Fowler C.J. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49 (2006) 644-650
7. Heinen F., Molenaers G., Fairhurst C., Carr L.J., Desloovere K., Chaleat Valayer E., et al. European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 10 (2006) 215-225
8. Dykstra D.D., and Sidi A.A. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 71 (1990) 24-26
9. Stöhrer M., Schurch B., Kramer G., Schmidt D., Gaul D., and Hauri D. Botulinum A toxin in the treatment of detrusor hyperreflexia in spinal cord injury. A new alternative to medical and surgical procedures?. Neurourol Urodyn 18 (1999) 401-402
10. Schulte-Baukloh H., Michael T., Schobert J., Stolze T., and Knispel H.H. Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59 (2002) 325-327 [discussion: 327-8]
11. Schulte-Baukloh H., Michael T., Sturzebecher B., and Knispel H.H. Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44 (2003) 139-143
12. Riccabona M., Koen M., Schindler M., Goedele B., Pycha A., Lusuardi L., et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171 (2004) 845-848
13. Schulte-Baukloh H., Knispel H.H., Stolze T., Weiss C., Michael T., and Miller K. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 66 (2005) 865-870
14. Altaweel W., Jednack R., Bilodeau C., and Corcos J. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol 175 (2006) 1102-1105
15. Kajbafzadeh A.M., Moosavi S., Tajik P., Arshadi H., Payabvash S., Salmasi A.H., et al. Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele. Urology 68 (2006) 1091-1096 [discussion: 1096-7]
16. McGuire E.J., and Savastano J.A. Urodynamics and management of the neuropathic bladder in spinal cord injury patients. J Am Paraplegia Soc 8 (1985) 28-32
17. ®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 53 (2008) 275-287
18. Schurch B., Schmid D.M., and Stohrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342 (2000) 665
19. Neel K.F., Soliman S., Salem M., Seida M., Al-Hazmi H., and Khatab A. Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. J Urol 178 (2007) 2593-2597 [discussion: 2597-8]
20. Molenaers G., Desloovere K., Eyssen M., De Cat J., Jonkers I., and De Cock P. Botulinum toxin type A treatment of cerebral palsy: an integrated approach. Eur J Neurol 6 (1999) S51-S57
21. Molenaers G., Desloovere K., Fabry G., and De Cock P. The effects of quantitative gait assessment and botulinum toxin A on musculoskeletal surgery in children with cerebral palsy. J Bone Joint Surg Am 88 (2006) 161-170
22. Heinen F., Schroeder A.S., Fietzek U., and Berweck S. When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy. Mov Disord 21 (2006) 2029-2030
23. Bartonek A., Gutierrez E.M., Haglund-Akerlind Y., and Saraste H. The influence of spasticity in the lower limb muscles on gait pattern in children with sacral to mid-lumbar myelomeningocele: a gait analysis study. Gait Posture 22 (2005) 10-25
24. Ozaras N., Yalcin S., Ofluoglu D., Gureri B., Cabukoglu C., and Erol B. Are some cases of spina bifida combined with cerebral palsy? A study of 28 cases. Eura Medicophys 41 (2005) 239-242
25. Heinen F., Korinthenberg R., Stücker R., and Deuschl G. Dystonic posture of lower extremities associated with myelomeningocele: successful treatment with botulinum A toxin in a sixmonth-old child. Neuropediatrics 26 (1995) 214-216